Not logged in Share Save
Share Save
Share Save
Share Save
Share Save
Share Save
Share Save
Share Save
Share Save
Share Save
Automatic detection and multi-component segmentation of brain metastases in longitudinal MRI Andrearczyk, Vincent; Schiappacasse, Luis; Abler, Daniel; Wodzinski, Marek; Hottinger, Andreas; Raccaud, Matthieu; Bourhis, Jean; Prior, John O.; Dunet, Vincent; Depeurnge, Adrien Share Save
Share Save
Survival Without Quality of Life Deterioration in the GORTEC 2014-04 OMET Randomized Phase 2 Trial in Patients with Head and Neck Cancer with Oligometastases using Stereotactic Ablative Radiation Therapy (SABR) alone or Chemotherapy and SABR Thariat, Juliette; Bosset, Mathieu; Falcoz, Antoine; Vernerey, Dewi; Pointreau, Yoann; Racadot, Severine; Faivre, Jean-Christophe; Castelli, Joel; Guihard, Sebastien; Huguet, Florence; Chapet, Sophie; Tao, Yungan; Borel, Christian; Fayette, Jerome; Rambeau, Audrey; Ferrand, Francois Regis; Pechery, Adeline; Bourhis, Jean; Sun, Xu-Shan Share Save
Results of the multicenter phase II FRAIL-IMMUNE trial evaluating the efficacy and safety of durvalumab (D) combined with weekly paclitaxel carboplatin in 1st-line in patients with recurrent/metastatic squamous cell carcinoma of the head and neck (R/M SCCHN) not eligible to cisplatin Fayette, J.; Cropet, C.; Gautier, J.; Toullec, C.; Vinches, M.; Burgy, M.; Iacob, M.; Kaminsky-Forrett, M-C.; Salas, S.; Linot, B.; Champagnac, A.; Sondarjee, I.; Pechery, A.; Perol, D.; Bourhis, J. Share Save
Avelumab-cetuximab-radiotherapy (RT) versus standards of care in patients with locally advanced squamous cell carcinoma of head and neck (LA-SCCHN): Final analysis of randomized phase III GORTEC 2017-01 REACH trial Tao, Y.; Auperin, A.; Sun, X.; Liem, X.; Sire, C.; Martin, L.; Pointreau, Y.; Borel, C.; Kaminsky-Forrett, M-C.; Miroir, J.; Rolland, F.; Coutte, A.; Clatot, F.; Sinigaglia, L.; Thariat, J.; Even, C.; Saada, E. B.; Guigay, J.; Bourhis, J. Share Save
Share Save
Standard versus fractionated high-dose cisplatin plus radiation for locally advanced head and neck cancer: Results of the CisFRad (GORTEC 2015-02) randomized phase II trial Borel, Christian; Sun, Xu-Shan; Coutte, Alexandre; Bera, Guillaume; Sire, Christian; Zanetta, Sylvie; Alfonsi, Marc; Janoray, Guillaume; Chatellier, Thierry; Garcia-Ramirez, Muriel; Gherga, Elisabeta; Hammoud, Yasser; Burgy, Mickael; Etienne-Selloum, Nelly; Pechery, Adeline; Girard-Calais, Marie-Helene; Velten, Michel; Pignon, Jean-Pierre; Wanneveich, Mathilde; Bourhis, Jean Share Save
Share Save
Adapted EXTREME regimen in the first-line treatment of fit older patients with recurrent or metastatic head and neck squamous cell carcinoma (ELAN-FIT): a multicentre, singlearm, phase 2 trial Guigay, Joel; Le Caer, Herve; Ferrand, Francois-Regis; Geoffrois, Lionel; Saada-Bouzid, Esma; Fayette, Jerome; Sire, Christian; Cupissol, Didier; Blot, Emmanuel; Guillet, Pierre; Pavillet, Julien; Bozec, Laurence; Capitain, Olivier; Rolland, Frederic; Debourdeau, Philippe; Pointreau, Yoann; Falandry, Claire; Lopez, Stephane; Coutte, Alexandre; Chatellier, Thierry; Dalloz, Pierre; Ortholan, Cecile; Michel, Cecile; Lacas, Benjamin; Cheurfa, Nadir; Schwob, Dominique; Bourhis, Jean; Mertens, Cecile; Auperin, Anne Share Save
Very high-energy electron therapy as light-particle alternative to transmission proton FLASH therapy - An evaluation of dosimetric performances Bohlen, Till Tobias; Germond, Jean-Francois; Desorgher, Laurent; Veres, Izabella; Bratel, Andreas; Landstrom, Eric; Engwall, Erik; Herrera, Fernanda G.; Ozsahin, Esat Mahmut; Bourhis, Jean; Bochud, Francois; Moeckli, Raphae l Share Save
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png)
ANNALS OF ONCOLOGY.png)
.png){kind=icon}
Share.png){kind=icon}
Save